Therefore, the human colonic adenocarcinoma cell line HT-29 (47.5–95% of CD133+ population) was chosen as a model for this study and comparing with human colonic adenocarcinoma cell line LS174T (0.45% of CD133+ population). The gene discussed is PROM1; the disease is colon adenocarcinoma.